Susan G. Komen is marking a significant milestone in the effort to improve care and outcomes for people facing inflammatory breast cancer (IBC).
CURE Fall 2025
Perioperative immunotherapy for the treatment of non-small cell lung cancer is starting to exhibit survival benefits among patients, research has shown.
This issue of CURE highlights personal stories and expert insights, from living with multiple diagnoses to self-advocacy, nutrition and survivorship care.
Over the past 20 years, there have been dramatic advances in treatment options for people diagnosed with non-small cell lung cancer
Advertisement
Advertisement
Trending on CURE
1
Understanding Stage 2 Kidney Cancer (Renal Cell Carcinoma)
2
FDA Grants Orphan Drug Designation to AMXT 1501 With DFMO in Neuroblastoma
3
Reclaiming Intimacy for Women After Cancer
4
A Cancer Portrait Hidden in the Attic of My Mind
5
